When Cancer Immunotherapy Attacks the Pituitary: Largest Case-Based Analysis Maps Nivolumab-Induced Hypophysitis
A patient-level synthesis of 40 published cases shows that nivolumab-induced hypophysitis predominantly damages the pituitary's cortisol-regulating axis, responds well to ...
